Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,010,865
  • Shares Outstanding, K 137,720
  • Annual Sales, $ 86,180 K
  • Annual Income, $ -615,060 K
  • EBIT $ -609 M
  • EBITDA $ -598 M
  • 60-Month Beta 0.49
  • Price/Sales 11.78
  • Price/Cash Flow N/A
  • Price/Book 0.82

Options Overview Details

View History
  • Implied Volatility 152.22% ( +1.60%)
  • Historical Volatility 79.98%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 152.22% on 12/20/24
  • IV Low 22.09% on 08/13/24
  • Put/Call Vol Ratio 4.30
  • Today's Volume 159
  • Volume Avg (30-Day) 1,143
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 32,058
  • Open Int (30-Day) 25,625

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.85
  • Number of Estimates 5
  • High Estimate -0.66
  • Low Estimate -0.96
  • Prior Year -0.86
  • Growth Rate Est. (year over year) +1.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.56 +11.89%
on 11/21/24
10.00 -26.60%
on 12/03/24
+0.60 (+8.90%)
since 11/20/24
3-Month
6.56 +11.89%
on 11/21/24
10.44 -29.69%
on 11/06/24
-0.42 (-5.41%)
since 09/20/24
52-Week
6.56 +11.89%
on 11/21/24
13.09 -43.93%
on 06/05/24
-2.27 (-23.62%)
since 12/20/23

Most Recent Stories

More News
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

SBFM : 2.78 (-0.71%)
MRNA : 39.39 (-0.43%)
PFE : 26.36 (+2.29%)
INO : 1.8400 (-0.27%)
VIR : 7.34 (-0.41%)
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

SBFM : 2.78 (-0.71%)
MRNA : 39.39 (-0.43%)
PFE : 26.36 (+2.29%)
INO : 1.8400 (-0.27%)
VIR : 7.34 (-0.41%)
From laggards to leaders: Small caps on the rise

Despite large-cap dominance, signs suggest a shift to small-cap leadership. Valuations, positive Q3 results, and historical patterns point to potential gains.

MDY : 570.23 (+0.72%)
TSLA : 421.06 (-3.46%)
XLC : 97.96 (+0.54%)
IWM : 221.92 (+0.94%)
RCL : 238.43 (+3.32%)
XLK : 235.96 (+1.49%)
NVDA : 134.70 (+3.08%)
META : 585.25 (-1.73%)
SPSM : 45.44 (+0.58%)
SPY : 591.15 (+1.20%)
VIR : 7.34 (-0.41%)
RCUS : 15.50 (+0.26%)
The Five Biotech Stocks Every Investor Should Know About

Avalon GloboCare Corp., (NASDAQ: ALBT) a developer of innovative precision diagnostics and provider of clinical laboratory services just announced that the United States Patent and Trademark Office (USPTO)...

ALBT : 3.42 (-12.08%)
INSM : 70.44 (+1.48%)
VIR : 7.34 (-0.41%)
CODX : 0.7300 (+0.66%)
ANTX : 1.2600 (-0.79%)
A Potentially Revolutionary Tuberculosis Test Can Produce Results in 24 Hours

With a rising prevalence of chronic diseases, we’re starting to see higher demand for clinical lab services. That being said, it’s no surprise that, according to Market.Us, the global market for clinical...

INSM : 70.44 (+1.48%)
VIR : 7.34 (-0.41%)
CODX : 0.7300 (+0.66%)
ANTX : 1.2600 (-0.79%)
ALBT : 3.42 (-12.08%)
Is Vir Biotechnology Stock a Buy?

The biotech is out to prove that it isn't just a "pandemic stock."

VIR : 7.34 (-0.41%)
Why Shares of Vir Biotechnology Are Plunging Thursday

The company had disappointing trial news for one of its lead therapies.

GSK : 33.60 (+0.51%)
GILD : 92.57 (+1.62%)
VIR : 7.34 (-0.41%)
Brii Biosciences Provides Latest Clinical Development and Corporate Updates

Company extends BRII-179 license to global rights and introduces preventive vaccine, PreHevbri® in Greater China and Asia Pacific markets New data from...

VIR : 7.34 (-0.41%)
VBIV : 0.0653 (-50.87%)
ANTX : 1.2600 (-0.79%)
Brii Bio Announces New Data from Partners Underscoring Potential for HBV Functional Cure at EASLâ„¢ Congress 2023

/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio", "we", or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve...

VIR : 7.34 (-0.41%)
VBIV : 0.0653 (-50.87%)
Why Shares of Keros Therapeutics Jumped This Week

The company appointed a new director and an analyst reiterated his position on the stock.

BIIB : 146.47 (-0.62%)
VIR : 7.34 (-0.41%)
KROS : 17.03 (+0.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The company's development pipeline consists of product candidates targeting the hepatitis B virus, influenza A, human immunodeficiency virus...

See More

Key Turning Points

3rd Resistance Point 7.85
2nd Resistance Point 7.71
1st Resistance Point 7.52
Last Price 7.34
1st Support Level 7.19
2nd Support Level 7.05
3rd Support Level 6.86

See More

52-Week High 13.09
Fibonacci 61.8% 10.60
Fibonacci 50% 9.82
Fibonacci 38.2% 9.05
Last Price 7.34
52-Week Low 6.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar